Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Some Covered CpG sites is extremely high for RRBS with BiSeq package

    I am using BiSeq package following bismark tools for RRBS analysis. I termed Covfiles as a BSraw file to include all the used 20 samples, and below is what it returns when I call covStatistics(Covfiles)

    > Covfiles
    class: BSraw
    dim: 5542384 20
    metadata(0):
    assays(2): totalReads methReads
    rownames(5542384): 1 2 ... 5542383 5542384
    rowData names(0):
    colnames(20): 5AD0 5AD1 ... PBD5 PBD7
    colData names(1): group

    > covStatistics(Covfiles)
    $Covered_CpG_sites
    5AD0 5AD1 5AD3 5AD5 5AD7 FAD0 FAD1 FAD3
    3202085 3176893 3068230 3138142 3046918 1352823 3302600 2980850
    FAD5 FAD7 NSD0 NSD1 NSD3 NSD5 NSD7 PBD0
    2997963 3098611 3400952 3413895 2913465 3164717 3108568 3114307
    PBD1 PBD3 PBD5 PBD7
    2392880 3189085 2932880 3188629

    $Median_coverage
    5AD0 5AD1 5AD3 5AD5 5AD7 FAD0 FAD1 FAD3 FAD5 FAD7 NSD0 NSD1 NSD3 NSD5
    5 5 5 5 4 3 4 4 4 5 4 3 2 2
    NSD7 PBD0 PBD1 PBD3 PBD5 PBD7
    5 6 3 7 5 6



    But I found some site is covered extremely higher than others when I use

    covBoxplots(Covfiles, col = "cornflowerblue", las = 2)

    I don't quite sure whether this is right or not. Is anyone could tell me how is my data looks like, and why there are so many strange sites?


    > sessionInfo()
    R version 3.3.0 (2016-05-03)
    Platform: x86_64-apple-darwin13.4.0 (64-bit)
    Running under: OS X 10.11.5 (El Capitan)

    locale:
    [1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8

    attached base packages:
    [1] parallel stats4 stats graphics grDevices utils
    [7] datasets methods base

    other attached packages:
    [1] BiSeq_1.12.0 Formula_1.2-1
    [3] SummarizedExperiment_1.2.2 Biobase_2.32.0
    [5] GenomicRanges_1.24.2 GenomeInfoDb_1.8.1
    [7] IRanges_2.6.0 S4Vectors_0.10.1
    [9] BiocGenerics_0.18.0

    loaded via a namespace (and not attached):
    [1] XVector_0.12.0 bitops_1.0-6
    [3] tools_3.3.0 zlibbioc_1.18.0
    [5] annotate_1.50.0 RSQLite_1.0.0
    [7] lattice_0.20-33 Matrix_1.2-6
    [9] DBI_0.4-1 rtracklayer_1.32.0
    [11] Biostrings_2.40.2 lmtest_0.9-34
    [13] grid_3.3.0 nnet_7.3-12
    [15] globaltest_5.26.0 flexmix_2.3-13
    [17] AnnotationDbi_1.34.3 XML_3.98-1.4
    [19] survival_2.39-2 BiocParallel_1.6.2
    [21] lokern_1.1-6 Rsamtools_1.24.0
    [23] modeltools_0.2-21 sfsmisc_1.1-0
    [25] GenomicAlignments_1.8.3 splines_3.3.0
    [27] xtable_1.8-2 betareg_3.0-5
    [29] sandwich_2.3-4 RCurl_1.95-4.8
    [31] zoo_1.7-13
    Attached Files

  • #2
    That happens quite a bit. My guess is that those are PCR duplicates. I've normally filtered out the top ~0.1% of covered sites from RRBS datasets.

    Comment


    • #3
      Originally posted by dpryan View Post
      That happens quite a bit. My guess is that those are PCR duplicates. I've normally filtered out the top ~0.1% of covered sites from RRBS datasets.
      Thank you Ryan, May I ask how do you filter the top ~0.1% of covered sites? Is it also done by BiSeq package?

      Comment


      • #4
        I usually do it in R, so presumably one can do that with the BSraw object.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Understanding Genetic Influence on Infectious Disease
          by seqadmin




          During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

          Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
          09-09-2024, 10:59 AM
        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, Today, 06:25 AM
        0 responses
        13 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, Yesterday, 01:02 PM
        0 responses
        12 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-18-2024, 06:39 AM
        0 responses
        14 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-11-2024, 02:44 PM
        0 responses
        14 views
        0 likes
        Last Post seqadmin  
        Working...
        X